Reaktion #59692
ord-2424ec4cbf2e42b79cc92714c1aa57a5
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1workup.STIRRINGthe reaction stirred at room temperature for 18 hours
- 2SonstigeThe solvent was evaporated under vacuum
- 3Sonstigethe reaction partitioned between ethyl acetate (250 ml) and water (50 ml)
- 4WaschenThe organic phase was washed with hydrochloric acid (2N, 50 ml) and aqueous sodium bicarbonate (1M, 50 ml)
- 5Trocknendried (magnesium sulphate)
- 6Sonstigethe solvent evaporated under vacuum
- 7SonstigeThe residue was absorbed onto silica
- 8Sonstigepurified by flash column chromatography
- 9Wascheneluting with cyclohexane/ethyl acetate (4:1)
- 10SonstigeThe solvent was evaporated from the product fractions under vacuum
Vorschrift
4-Methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoic acid (Intermediate 21) (2.0 g, 7.63 mmol), DIPEA (4 ml, 22.89 mmol) and HATU (3.05 g, 8.02 mmol) were dissolved in DMF (20 ml) and stirred at room temperature for 15 mins. 2-Aminothiazole (801 mg, 8.01 mmol) was added and the reaction stirred at room temperature for 18 hours. The solvent was evaporated under vacuum and the reaction partitioned between ethyl acetate (250 ml) and water (50 ml). The organic phase was washed with hydrochloric acid (2N, 50 ml) and aqueous sodium bicarbonate (1M, 50 ml), then dried (magnesium sulphate) and the solvent evaporated under vacuum. The residue was absorbed onto silica and purified by flash column chromatography eluting with cyclohexane/ethyl acetate (4:1). The solvent was evaporated from the product fractions under vacuum to give 4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-N-(thiazol-2-yl)-benzamide (1.72 g).